|
業務類別
|
Biotechnology |
|
業務概覽
|
Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway in cells that enables sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships. |
| 公司地址
| 675 West Kendall Street, Henri A. Termeer Square, Cambridge, MA, USA, 02142 |
| 電話號碼
| +1 617 551-8200 |
| 傳真號碼
| +1 617 551-8101 |
| 公司網頁
| https://www.alnylam.com |
| 員工數量
| 2500 |
| Mr. Kevin Joseph Fitzgerald, PhD |
Executive Vice President, Chief Scientific Officer and Head, Early Research and Early Development |
美元 586.60K |
24/03/2025 |
| Dr. Yvonne L Greenstreet, MB.Ch.B. |
Director and Chief Executive Officer |
美元 1.25M |
12/02/2026 |
| Mr. Jeffrey V. Poulton |
Executive Vice President, Chief Financial Officer and Principal Accounting Officer |
美元 687.40K |
12/02/2026 |
| Dr. Pushkal P. Garg, M.D. |
Chief Medical Officer and Executive Vice President, Development and Medical Affairs |
美元 682.10K |
24/03/2025 |
| Mr. Tolga Tanguler |
Chief Commercial Officer |
美元 627.40K |
24/03/2025 |
|
|
| Dr. Elliott Sigal, M.D.,PhD |
Independent Director |
12/02/2026 |
| Dr. Margaret A. Hamburg, M.D. |
Independent Director |
12/02/2026 |
| Dr. Phillip A. Sharp,PhD |
Independent Director |
05/03/2025 |
| Mr. Stuart A. Arbuckle |
Independent Director |
12/02/2026 |
| Ms. Amy W. Schulman |
Chairman of the Board |
12/02/2026 |
| Dr. Yvonne L Greenstreet, MB.Ch.B. |
Director and Chief Executive Officer |
12/02/2026 |
| Mr. David E.I. Pyott, M.A.,M.B.A. |
Independent Director |
12/02/2026 |
| Dr. Dennis A. Ausiello, M.D. |
Independent Director |
12/02/2026 |
| Dr. Olivier Raymond Brandicourt, M.D. |
Independent Director |
12/02/2026 |
| Mr. Peter N. Kellogg |
Independent Director |
12/02/2026 |
| Ms. Colleen F. Reitan |
Independent Director |
12/02/2026 |
|
|
|
|
